Melanoma in Situ: Clinical Trials

9 trials for Melanoma in Situ, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 3 unknown, 1 completed, 1 terminated. 4 Not applicable, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable4Completed 1, Recruiting 1, Unknown 1, Withdrawn 1
Phase 32Recruiting 1, Terminated 1

Follow Melanoma in Situ: new trials by email Literature Review of Melanoma in Situ trials Research Report on Melanoma in Situ

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Using an Artificial Intelligence (AI) Tool for Melanoma Diagnosis
Clinical decision support tool - Malignant Melanoma of Skin, Other and Unspecified Malignant Neoplasm of Skin
Phase 3RecruitingMemorial Sloan Kettering Cancer Center140002026-10-152026-10-22
Early Detection of Skin Tumors Using a Telemedicine Tool in Primary Care
Intervention with telemedicine tool - Skin Cancer Prevention, Melanoma In Situ
Not applicableRecruitingInstitute of Health Information and Statistics of the Czech Republic14402026-02-012026-03-27
Effectiveness and Safety of X A-DERMâ„¢ Microsurfaced Acellular Dermal Matrix for Wound Healing After MOHS Surgery
A microsurfaced ADM (acellular dermal matrix) - Wound Healing After MMS Surgery, BCC - Basal Cell Carcinoma
Not applicableCompletedMcGuire Institute162025-08-082026-04-24
Clinical vAlidation of a MobilE appLication ("ProRodinki") in the Assessment of the maLignant skIn neoplAsms
Mobile phone application "ProRodinki" - Melanoma (Skin), Nevus
Not applicableUnknownMelanomaPRO, Russia6052022-04-232022-06-02
Clinical Outcomes and Biomarkers in Patients With Stage 0-IV Melanoma in Real Clinical Practice
surgery (any volume) and / or pharmaceuticals treatment initiated or planned or only dynamic observation, in accordance with current clinical guidelines - Melanoma, Melanoma (Skin)
UnknownMelanomaPRO, Russia15702022-03-022022-06-15
Research of Pathological Imaging Diagnosis of Ocular Tumors Based on New Artificial Intelligence Algorithm
Melanoma (Skin), Melanoma in Situ
UnknownPeking University1002020-12-312021-01-05
Pre-Treatment of Highly Suspicious Pigmented Skin Lesions With Interleukin-2
Aldesleukin, Saline - Melanoma (Skin), Melanoma in Situ
Phase 3TerminatedCarman Giacomantonio12019-10-302024-07-24
Mohs and Immunofluorescence for Malignant Melanoma In Situ
H&E, IHC MART-1, IF MART-1 - Lentigo Maligna, Melanoma In Situ
Not applicableWithdrawnUniversity of Miami2015-06-012019-01-07
BioMEL- Diagnostic and Prognostic Factors in Melanoma.
Imaging - Melanoma, Melanoma in Situ
RecruitingRegion Skane20002013-11-042024-01-23

Narrower conditions

Melanoma (7)  ·  Nevus (4)  ·  Carcinoma, Basal Cell (3)  ·  Carcinoma, Squamous Cell (2)  ·  Nevus, Pigmented (2)  ·  Skin Neoplasms (2)  ·  Bowen's Disease (1)  ·  Dysplastic Nevus Syndrome (1)  ·  Eye Neoplasms (1)  ·  Hemangioma (1)  ·  Hutchinson's Melanotic Freckle (1)  ·  Keratosis, Seborrheic (1)  ·  Nevus, Epithelioid and Spindle Cell (1)  ·  Nevus, Halo (1)  ·  Squamous Intraepithelial Lesions (1)

Broader conditions

Neoplasms (9)  ·  Neoplasms by Histologic Type (9)  ·  Neoplasms, Germ Cell and Embryonal (8)  ·  Neoplasms, Nerve Tissue (8)  ·  Neuroectodermal Tumors (8)  ·  Neuroendocrine Tumors (8)  ·  Nevi and Melanomas (8)  ·  Neoplasms by Site (7)  ·  Skin Diseases (7)  ·  Skin and Connective Tissue Diseases (7)  ·  Skin Neoplasms (5)  ·  Carcinoma (3)  ·  Neoplasms, Basal Cell (3)  ·  Neoplasms, Glandular and Epithelial (3)  ·  Eye Diseases (2)

Interventions

Dermoscopy (1)  ·  Diagnostic Imaging (1)  ·  Genome (1)  ·  Sodium Chloride (1)  ·  Surgical Procedures, Operative (1)  ·  aldesleukin (1)

Sponsors

MelanomaPRO, Russia (2)  ·  Carman Giacomantonio (1)  ·  Institute of Health Information and Statistics of the Czech Republic (1)  ·  McGuire Institute (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  Peking University (1)  ·  Region Skane (1)  ·  University of Miami (1)

Countries

United States (3)  ·  Russia (2)  ·  Canada (1)  ·  Czechia (1)  ·  Sweden (1)

Top investigators

Aaron Farberg, MD (1)  ·  Carman A Giacomantonio, MD, FRCSC (1)  ·  Chun Zhang, MD/PHD (1)  ·  Igor V Samoylenko (1)  ·  James Grichnik, MD, PhD (1)  ·  Kari Nielsen, Ass. Prof. (1)  ·  Lev V Demidov, Professor (1)  ·  Mike Drake (1)  ·  Petr Arenberger, prof. (1)  ·  Veronica Rotemberg, MD (1)

Results publications

PMID 38309755, PMID 39469641

NIH funding

R01CA293974 (1)